LDL-C plays a causal role on T2DM: a Mendelian randomization analysis

Area of Science:

• Genetics
• Metabolic Diseases
• Epidemiology

Background:

• Diabetic dyslipidemia is prevalent in Type 2 diabetes mellitus (T2DM).
• Statins, used to lower LDL-C, are associated with increased T2DM incidence, suggesting a potential causal link.
• Genetic factors may mediate the relationship between LDL-C and T2DM.

Purpose of the Study:

• To investigate the causal relationship between low-density lipoprotein cholesterol (LDL-C) and Type 2 diabetes mellitus (T2DM).
• To utilize Mendelian Randomization (MR) analysis with genetic variations as instrumental variables (IVs).

Main Methods:

• A two-sample MR analysis was performed.
• 23 single nucleotide polymorphisms (SNPs) associated with LDL-C were selected as IVs from a large-scale genome-wide association study (GWAS) of European ancestry.
• The penalized robust inverse-variance weighted (IVW) method was employed to assess the causal effect.

Main Results:

• Elevated LDL-C levels were found to significantly increase the risk of T2DM (Beta = 0.24, P = 0.002).
• No significant causal relationship was observed between LDL-C and Type 1 diabetes mellitus (T1DM) (Beta = -0.202, P = 0.883).

Conclusions:

• This study provides genetic evidence supporting a causal link between higher LDL-C levels and an increased risk of T2DM.
• The findings suggest that interventions targeting LDL-C may have implications for T2DM prevention or management.
• The analysis did not find a similar association for Type 1 diabetes mellitus.